GENEDRIVE PLC
GENEDRIVE PLC
Share · GB00B1VKB244 · A0ML2T (XLON)
Overview Financial Indicators
0,01 GBP
-2,67 % -0,0004 GBP
Closing Price XLON 09.06.2025: 1,46 GBX
London (XLON) · Current prices and charts at MoneyPeak
09.06.2025 15:04

Current Prices from GENEDRIVE PLC

ExchangeTickerCurrencyLast TradePriceDaily Change
XLON: London
London
GDR.L
GBX
09.06.2025 15:04
1,46 GBX
1,47 GBX
-0,68 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
-2,67 % -5,44 % -1,42 % -28,74 % -25,89 % -11,52 % -98,63 %

Company Profile for GENEDRIVE PLC Share

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive, a patented small polymerase chain reaction, which enables rapid nucleic acid amplification and detection from various sample types, including plasma, sputum, and buccal swabs. Its Genedrive platform offers Genedrive HCV ID Kit, a qualitative molecular solution for Hepatitis C Virus testing; Genedrive BioPlex for the rapid determination of military biothreats from pathogens; Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and Genedrive Connect app, an android-based mobile app that allows added data management flexibility and results transmission. The company serves biotechnology and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. It has a collaboration agreement with Beckman Coulter Life Sciences to automate the laboratory PCR testing process for COVID-19. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom.

Company Data

Name GENEDRIVE PLC
Company genedrive plc
Website https://www.genedriveplc.com
Primary Exchange XLON London
WKN A0ML2T
ISIN GB00B1VKB244
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Dr. Gino Miele Ph.D.
Country United Kingdom
Currency GBP
Employees 0,0 T
Address The CTF Building, M13 9XX Manchester
IPO Date 2007-04-04

Stock Splits

Date Split
14.05.2024 5:4

Ticker Symbols

Name Symbol
Frankfurt D6M.F
London GDR.L

More Shares

Investors who GENEDRIVE PLC hold also have the following shares in their portfolio:
DZ BANK CLN E.9981
DZ BANK CLN E.9981 Bond
NYKREDIT 21/31 FLR MTN
NYKREDIT 21/31 FLR MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025